2023 KEYNOTE SPEAKER

Dr. Thomas Lechner joined Ono Pharma US in April 2022, assuming the role of Vice President, Medical Affairs, where he is responsible for establishing the company’s core medical strategy in the US.

Dr. Thomas Lechner from Ono Pharma US will be talking about a new research study that is underway for men and women with primary central nervous system lymphoma (PCNSL).

2023 SPEAKER

As the Rehab Program Coordinator at Barrow Neurological Institute
Ashley is the co-founder of the nation’s first program to address traumatic brain injury in the domestic violence population, She has dedicated her career as a social worker to address and bring awareness to traumatic brain injury in vulnerable populations through community and direct clinical care.

2023 SPEAKER

Dr. Hood is a veteran of the California life science community who has founded and led several successful biotechnology companies in his 20-year career. He is currently Founder, CEO and Executive Chairman of Endeavor Biomedicines, a company funded in 2021 to develop novel therapeutics for oncology and idiopathic pulmonary fibrosis. Prior to that, John was the Founder and CEO of Impact Biomedicines (now owned by Bristol-Myers Squibb), the developer of fedratinib, which has subsequently been approved worldwide for the treatment of myelofibrosis. He began his career as Director of Research at TargeGen in 2001, where he co-discovered fedratinib and led a team identifying small molecule therapeutics for the treatment of cancer and eye disease. John is an inventor on 100+ patents and the author of 50+ scientific articles. He received his Ph.D. in Medical Physiology and a B.S. in Biochemistry from Texas A&M University.

2023 SPEAKER

Chief Medical Officer, SVP of Plus Therapeutics

2023 SPEAKER

Neurosurgeon, Radiosurgeon
Medical Director, Neurosurgery and Neuro-Oncology at Novcure

If you haven't already nominated a Brain Tumor Patient who inspires you, be sure to do so by May 5th, 2024! Click the button below to nominate.

2023 SPEAKER

Dr. McCracken is a board-certified, fellowship trained Neurosurgical Oncologist who specializes in the surgical treatment of primary and metastatic tumors affecting the brain, pituitary gland and skull-base. He is well-versed in many different surgical approaches including open and minimally invasive craniotomies, endoscopic approaches to the skull base and pituitary gland, and stereotactic radiosurgery with both Gamma Knife and Linear Accelerator based technology. He leads the Piedmont Neurosurgical Oncology Service, is Co-Director of the Piedmont Brain Tumor Center.

2023 SPEAKER

Co-Founder & Chief Medical Officer, Imvax